Avammune Therapeutics Company
Avammune Therapeutics is a drug discovery company focused on immuno-oncology and especially the STING pathway. Avammune is developing a multimodal approach to modulate the STING pathway to treat cancer. Their multimodal approach employs a combination of engineered viruses and small molecules.
Last Funding Date:
2025-05-07
Total Funding:
12000000
Founded Date:
2017-01-01
Headquarters:
Philadelphia,Pennsylvania,United States,North America
Employee Number:
11-50
Funding Status:
private
Industry:
Quantum Biology
Super Industry:
Quantum Science Applications
Funding Stage:
Early Stage Venture
Funding Total Value:
12000000
Last Funding Total Usd:
12000000
Last Funding Total Currency:
USD
Last Funding Total Value:
12000000
Founders:
Aditya Kulkarni,Arun Papaiah